SCHEMBL7146199

SCHEMBL7146199

Cc1nccn1-c1cccc(C(=O)CC(=O)Nc2cc(-c3ccccc3F)c(OC(C)(C)C)cc2NC(=O)OC(C)(C)C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAPT P10636 2/20 0.36
TP53 P04637 3/20 0.35
NR3C2 P08235 1/20 0.35
LMNA P02545 1/20 0.34
BRD4 O60885 1/20 0.34
F10 P00742 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
PORCN Q9H237 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TSHR P16473 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
KCNH2 Q12809 1/20 0.32
CACNA1C Q13936 1/20 0.32
SCN5A Q14524 1/20 0.32
GPR142 Q7Z601 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141959 0.94 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2MAPTTP53NR3C2
SCHEMBL7704777 0.93 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2MAPTTP53NR3C2
SCHEMBL7143546 0.91 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2MAPTTP53LMNA
SCHEMBL7141292 0.90 MAPT (0.36) ALDH1A1SMN1; SMN2MAPTTP53NR3C2
SCHEMBL5868865 0.88 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2MAPTTP53NR3C2
SCHEMBL7139910 0.87 CYP3A4 (0.34) ALDH1A1SMN1; SMN2BRD4CYP3A4TSHR
SCHEMBL7139875 0.86 ABL1 (0.41) BRD4F10CYP3A4L3MBTL1
SCHEMBL7705335 0.85 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MAPTTP53LMNA
SCHEMBL7699016 0.85 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MAPTTP53LMNA
SCHEMBL7703856 0.83 CYP3A4 (0.37) ALDH1A1SMN1; SMN2MAPTTP53NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed